129 материалов по теме, собраны автоматически из проверенных источников
Targeted radioactive therapy may help delay spread of recurrent prostate cancer, UCLA study suggests | Newswise Newswise
Beyond hormone therapy: what’s the next wave in prostate cancer? Labiotech.eu
Men in England diagnosed with incurable advanced prostate cancer are more likely to survive for at least three years than they were a decade ago, according to an analysis by the London School of Hygiene & Tropical Medicine (LSHTM) and partners.
Dual-masked T-cell Engager VIR-5500 Received FDA Fast Track Designation for the Treatment of Prostate Cancer Business Wire
New Prostate Cancer Foundation Cardiovascular Risk Framework for Patients Receiving Hormone Therapy Published in JCO Oncology Practice Business Wire
Single Transfer RNA Helps Drive Prostate Cancer Aggression and Resistance Technology Networks
A new study revealed molecular features linked to more aggressive prostate cancer in a subset of patients who had been classified as low risk, highlighting biological differences that may not be apparent from clinical measures alone. The results could lead to new therapeutic strategies.
Key Driver of Aggressive Prostate Cancer Identified, Suggesting New Way to Reverse Drug Resistance | Newswise Newswise
Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine whether prostate tumors remain sensitive to treatment or evolve into a more aggressive, drug-resistant form of the disease.
Metastatic Castration-Resistant Prostate Cancer Clinical Trial Pipeline Appears Robust With 75+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight StreetInsider
Metastatic Prostate Cancer Clinical Trial Pipeline Gains Momentum: 80+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight StreetInsider
Prostate Cancer Foundation Honors Mary-Ellen Taplin, MD, with the 2026 PCF Women in Science Lifetime Achievement Award Business Wire
Clinical significance of circulating macrophage markers across different stages of prostate cancer: highlighting soluble CD163 Nature
The March of Innovation in Prostate Cancer [VIDEO] Cancer Health
New Theranostics Suite Provides Targeted Treatment of Prostate Cancer and Neuroendocrine Tumors University of Colorado Anschutz